Literature DB >> 25251922

Association of time to kidney transplantation with graft failure among U.S. patients with end-stage renal disease due to lupus nephritis.

Laura C Plantinga1, Rachel E Patzer, Cristina Drenkard, Michael R Kramer, Mitchel Klein, S Sam Lim, William M McClellan, Stephen O Pastan.   

Abstract

OBJECTIVE: Providers recommend waiting to transplant patients with end-stage renal disease (ESRD) secondary to lupus nephritis (LN), to allow for quiescence of systemic lupus erythematosus (SLE)-related immune activity. However, these recommendations are not standardized, and we sought to examine whether duration of time to transplant was associated with risk of graft failure in US LN-ESRD patients.
METHODS: Using national ESRD surveillance data (United States Renal Data System), we identified 4,743 US patients with LN-ESRD who received a first transplant on or after January 1, 2000 (followup through September 30, 2011). The association of wait time (time from ESRD start to transplant) with graft failure was assessed with Cox proportional hazards models, with splines of the exposure to allow for nonlinearity of the association and with adjustment for potential confounding by demographic, clinical, and transplant factors.
RESULTS: White LN-ESRD patients who were transplanted later (versus at <3 months receiving dialysis) were at increased risk of graft failure (3-12 months: adjusted hazard ratio [HR] 1.23, 95% confidence interval [95% CI] 0.93-1.63; 12-24 months: adjusted HR 1.37, 95% CI 0.92-2.06; 24-36 months: adjusted HR 1.34, 95% CI 0.92-1.97; and >36 months: adjusted HR 1.98, 95% CI 1.31-2.99). However, no such association was seen among African American recipients (3-12 months: adjusted HR 1.07, 95% CI 0.79-1.45; 12-24 months: adjusted HR 1.01, 95% CI 0.64-1.60; 24-36 months: adjusted HR 0.78, 95% CI 0.51-1.18; and >36 months: adjusted HR 0.74, 95% CI 0.48-1.13).
CONCLUSION: While future studies are needed to examine the potential confounding effect of clinically recognized SLE activity on the observed associations, these results suggest that longer wait times to transplant may be associated with equivalent or worse, not better, graft outcomes among LN-ESRD patients.
Copyright © 2015 by the American College of Rheumatology.

Entities:  

Mesh:

Year:  2015        PMID: 25251922      PMCID: PMC4370810          DOI: 10.1002/acr.22482

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  25 in total

1.  Race/ethnicity, poverty status, and renal transplant outcomes.

Authors:  Rebecca Press; Olveen Carrasquillo; Thomas Nickolas; Jai Radhakrishnan; Steven Shea; R Graham Barr
Journal:  Transplantation       Date:  2005-10-15       Impact factor: 4.939

2.  Influence of pretransplantation dialysis time and lupus activity on outcome of kidney transplantation in systemic lupus erythematosus.

Authors:  M-C Chung; T-M Yu; K-H Shu; J-L Lan; D-Y Chen; H-C Ho; M-J Wu
Journal:  Transplant Proc       Date:  2014       Impact factor: 1.066

Review 3.  Clinical practice guidelines on wait-listing for kidney transplantation: consistent and equitable?

Authors:  Pikli Batabyal; Jeremy R Chapman; Germaine Wong; Jonathan C Craig; Allison Tong
Journal:  Transplantation       Date:  2012-10-15       Impact factor: 4.939

4.  Recurrence of lupus nephritis after kidney transplantation.

Authors:  Gabriel Contreras; Adela Mattiazzi; Giselle Guerra; Luis M Ortega; Elaine C Tozman; Hua Li; Leonardo Tamariz; Cristiane Carvalho; Warren Kupin; Marco Ladino; Baudouin LeClercq; Isabel Jaraba; Decio Carvalho; Efrain Carles; David Roth
Journal:  J Am Soc Nephrol       Date:  2010-05-20       Impact factor: 10.121

5.  Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006.

Authors:  Karen H Costenbader; Amrita Desai; Graciela S Alarcón; Linda T Hiraki; Tamara Shaykevich; M Alan Brookhart; Elena Massarotti; Bing Lu; Daniel H Solomon; Wolfgang C Winkelmayer
Journal:  Arthritis Rheum       Date:  2011-06

6.  Discrepancy between Medical Evidence Form 2728 and renal biopsy for glomerular diseases.

Authors:  J Bradley Layton; Susan L Hogan; Caroline E Jennette; Barbara Kenderes; Jenna Krisher; J Charles Jennette; William M McClellan
Journal:  Clin J Am Soc Nephrol       Date:  2010-08-05       Impact factor: 8.237

7.  Outcomes of renal transplantation for recipients with lupus nephritis: analysis of the Organ Procurement and Transplantation Network database.

Authors:  Suphamai Bunnapradist; Philip Chung; Alice Peng; Andy Hong; Peter Chung; Brian Lee; Sumina Fukami; Steven K Takemoto; Ajay K Singh
Journal:  Transplantation       Date:  2006-09-15       Impact factor: 4.939

8.  Association of race and age with survival among patients undergoing dialysis.

Authors:  Lauren M Kucirka; Morgan E Grams; Justin Lessler; Erin Carlyle Hall; Nathan James; Allan B Massie; Robert A Montgomery; Dorry L Segev
Journal:  JAMA       Date:  2011-08-10       Impact factor: 56.272

9.  The influence of socioeconomic deprivation on outcomes following renal transplantation in the United kingdom.

Authors:  M R Stephens; M Evans; M A Ilham; A Marsden; A Asderakis
Journal:  Am J Transplant       Date:  2010-02-25       Impact factor: 8.086

Review 10.  A systematic review of barriers in access to renal transplantation among African Americans in the United States.

Authors:  Sankar D Navaneethan; Sonal Singh
Journal:  Clin Transplant       Date:  2006 Nov-Dec       Impact factor: 2.863

View more
  8 in total

1.  Methodological considerations in comparing access to Pre-emptive renal transplantation between SLE and other ESRD causes in the USRDS.

Authors:  Anna Broder; Wenzhu B Mowrey; Ladan Golestaneh; Chaim Putterman; Karen H Costenbader; Mimi Kim
Journal:  Semin Arthritis Rheum       Date:  2018-06-12       Impact factor: 5.532

2.  Differences in initial treatment modality for end-stage renal disease among glomerulonephritis subtypes in the USA.

Authors:  Michelle M O'Shaughnessy; Maria E Montez-Rath; Richard A Lafayette; Wolfgang C Winkelmayer
Journal:  Nephrol Dial Transplant       Date:  2015-11-25       Impact factor: 5.992

3.  Comparison of quality-of-care measures in U.S. patients with end-stage renal disease secondary to lupus nephritis vs. other causes.

Authors:  Laura C Plantinga; Rachel E Patzer; Cristina Drenkard; Stephen O Pastan; Jason Cobb; William McClellan; Sung Sam Lim
Journal:  BMC Nephrol       Date:  2015-03-29       Impact factor: 2.388

4.  Comparison of vascular access outcomes in patients with end-stage renal disease attributed to systemic lupus erythematosus vs. other causes: a retrospective cohort study.

Authors:  Laura C Plantinga; S Sam Lim; Rachel E Patzer; Stephen O Pastan; Cristina Drenkard
Journal:  BMC Nephrol       Date:  2016-07-07       Impact factor: 2.388

5.  Systematic review and meta-analysis of clinical outcomes comparison between different initial dialysis modalities in end-stage renal disease patients due to lupus nephritis prior to renal transplantation.

Authors:  Joel Swai; Xiexiong Zhao; Julie-Raisa Noube; Gui Ming
Journal:  BMC Nephrol       Date:  2020-05-01       Impact factor: 2.388

6.  COQ8B glomerular nephropathy: Outcomes after kidney transplantation and analysis of characteristics in Chinese population.

Authors:  Shuhan Zeng; Yuanyuan Xu; Cheng Cheng; Nannan Yu; Longshan Liu; Ying Mo; Lizhi Chen; Xiaoyun Jiang
Journal:  Front Pediatr       Date:  2022-08-10       Impact factor: 3.569

7.  Attribution of cause of end-stage renal disease among patients with systemic lupus erythematosus: the Georgia Lupus Registry.

Authors:  Laura C Plantinga; Cristina Drenkard; Stephen O Pastan; S Sam Lim
Journal:  Lupus Sci Med       Date:  2016-01-22

8.  Impact of pre-transplant time on dialysis on survival in patients with lupus nephritis.

Authors:  Eleana Ntatsaki; Alba Velo-Garcia; Vassilios S Vassiliou; Alan D Salama; David A Isenberg
Journal:  Clin Rheumatol       Date:  2018-05-11       Impact factor: 2.980

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.